Analyst Ratings for PTC Therapeutics (PTCT) [Neutrals]
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $73.00 (Cantor Fitzgerald)
- Lowest: $17.00 (Citi)
- Average: $35.71
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$35.71 (+23.1%)
* Over Last 12-Mos
Rating Score: 3.6 / 10 Percentile Rank: 34%
Rating Score: 3.6 / 10 Percentile Rank: 34%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/5/2023 | Truist Securities | Robyn Karnauskas | Downgrade | Hold (Buy) |
25.00 (N/A) |
21.20 (29.01) |
36.84% | Details |
3/17/2023 | Leerink Partners | Joseph P. Schwartz | New Coverage | Market Perform (N/A) |
48.00 (N/A) |
48.10 (29.01) |
-39.69% | Details |